Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Empowering Healthy Lifestyle Behavior Through Personalized Intervention Portfolios to Prevent and Control Obesity in the Elderly

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This pilot study will focus on men and women aged ≥60 years for a period of 3 months during which each participant will use the HLRS. The primary purpose is to study whether the HLRS, reflecting a multi-component intervention, is well accepted by the participant, has a decent adherence (i.e., user time of the app). In addition, investigators will study the feasibility of the design, i.e. whether the overall design is well suited to the participants, in order to improve their lifestyle, e.g., dietary habits and PA, among others. Secondary outcomes related to the feasibility approach include dietary habits, PA patterns, and selected plasma and urinary endpoints. This pilot study will be of longitudinal design without a control group. A later trial that is planned for the following year will focus further on biological endpoints and will be randomized. In this present pilot study, investigators aim to assess mainly the user-friendliness of the HLRS, and gather first evidence that the intervention can indeed produce healthier lifestyle patterns. The study's primary objective is to determine whether the developed HLRS can be successfully applied to the target population (men and women aged ≥60 years) and whether they use it frequently during the study and are satisfied with the HLRS. Secondly, investigators will study whether the assessment of endpoints required for the later and separately planned ensuing long-term study can be well assessed within the study and if, despite the limited time of the intervention duration, the intervention will be able to preliminary improve specific markers related to the risk of obesity and associated comorbidities. This will entail anthropometric measures to assess changes in body mass and body fat in addition to the primary and secondary objectives.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: t
View:

⁃ Individuals aged 60 or older:

• both males/females, general free-living population,

• residing in Luxembourg,

• having normal weight or being overweight, i.e., with a BMI between 18.5 ; 30 kg/m², which is considered a risk factor for developing obesity,

• owning a smartphone.

Locations
Other Locations
Luxembourg
Clinical and Epidemiological Investigation Center CIEC- LCTR
RECRUITING
Luxembourg
Contact Information
Primary
Torsten Bohn PhD, Adjunct Associate Professor
Torsten.Bohn@lih.lu
621763805
Time Frame
Start Date: 2025-11-19
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 30
Treatments
Experimental: Participant from the general population living in Luxembourg free of manifest diagnosed diseases
The following clinical visits and data collection points will be set up within the study:~1. Enrollment visit: the participant will sign the informed consent, the eligibility of the participant will be evaluated based on anthropometric measures, a urine spot sample, as well as general questionnaire. If found eligible, the participant can continue the study~2. Baseline visit: a number of questionnaires will be filled out by the participant, anthropometric data will be obtained, and a urine and blood sample will be taken, and a stool sample will be provided~3. Intermediate follow-up: this will consist of a phone interview or physical meeting~4. Final visit: a number of questionnaires will be filled anthropometric data, urine, blood and stool will be collected
Related Therapeutic Areas
Sponsors
Leads: Luxembourg Institute of Health
Collaborators: European Commission

This content was sourced from clinicaltrials.gov